Stocks and Investing Stocks and Investing
Wed, November 8, 2023

Gregory Fraser Maintained (AMRX) at Strong Buy with Increased Target to $7 on, Nov 8th, 2023


Published on 2024-10-28 07:26:03 - WOPRAI, Gregory Fraser
  Print publication without navigation


Gregory Fraser of Truist Securities, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $6 to $7 on, Nov 8th, 2023.

Gregory has made no other calls on AMRX in the last 4 months.



There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gregory


  • Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $5 on, Monday, August 7th, 2023
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $5 on, Monday, August 7th, 2023
Contributing Sources